Fresh analysis suggests that people who stop using popular weight-loss injections like Wegovy and Mounjaro can put back on shed pounds at a significantly accelerated pace than those who end conventional lifestyle regimens.
Published data in a major health publication demonstrates that while overweight people can lose a large proportion of their body weight while undergoing treatment, the mass is regained at an average rate of nearly a kilo each month upon discontinuation.
"People buying these treatments must be cognizant of the danger of quick rebound weight gain when the treatment is stopped," warns researcher Dr. Susan Jebb.
This pace of regain implies a return to starting weight within about a year and a half.
Comparing Therapies
The analysis, which reviewed dozens of trials involving thousands of patients, compared the outcomes of these new drugs with older methods.
Scientists note that individuals who shed pounds through lifestyle changes alone typically experience a more gradual weight regain—perhaps 100 grams monthly—post-intervention.
Understanding the Rapid Rebound
Doctors believe the mechanism of the jabs explains the accelerated rebound.
The injections copy a body's own chemical called glucagon-like peptide-1, which helps regulate hunger.
"Artificially providing GLP-1 concentrations several times higher than normal could lead to the body to produce less of its endogenous GLP-1, and could reduce sensitivity to its actions," noted Dr. Adam Collins, a dietetics expert.
"Withdrawal of this medication means appetite is unsuppressed, making binge eating a significant risk."
A Lifelong Condition?
Health authorities recommend the jabs for people with obesity-related medical conditions, accompanied by recommended diet and exercise modifications.
A number of clinicians argue that, given the significant potential of weight regain, the treatment is often ongoing.
This view is supported by pharmaceutical companies, who note that the findings "underscore the chronic nature of excess weight," similar to managing diseases like high blood pressure.
Patient Accounts
Individuals who have discontinued the jabs explain a powerful return of appetite.
"It felt as if something activating and you're instantly ravenous," recalled one woman.
This challenge is exacerbated if users have not established sustainable dietary or behavioural modifications during treatment.
Significant Adoption
Figures suggest that a significant number of people in the UK have used these injections in the past year, with interest continuing to grow.
- Use is more common among women than males.
- The 40s and 50s demographic shows the greatest usage rates.
- Many obtain the drugs through private prescriptions rather than the NHS.
In conclusion, clinicians emphasize that while GLP-1 drugs are powerful tools for weight loss, they are not a standalone cure and long-term success relies on ongoing lifestyle management.
